PRESS-NEWS.org - Press Release Distribution
PRESS RELEASES DISTRIBUTION

Hope for patients with HIV-associated cognitive impairment

Researchers discover compounds in green tea and chocolate may help reduce neurological complications linked to HIV

2012-08-14
(Press-News.org) Current drug therapy for patients with HIV is unable to control the complete replication of the virus in the brain. The drugs therefore do not have any effect against the complications associated with neurocognitive impairment in patients with HIV. New research by Joseph Steiner and colleagues from Johns Hopkins University has discovered that a group of plant polyphenols known as catechins, which naturally occur in green tea and the seed of the cacao tree, may help in the prevention of these neurological complications. Their work is published online in Springer's Journal of NeuroVirology.

Previous research has established the critical role of a protein called brain-derived neurotrophic factor (BDNF) in supporting the survival and growth of neurons in the brain. This protein is active in areas of the brain vital to learning, memory and higher thinking. Patients with HIV have been found to have lower levels of BDNF in their brains than healthy individuals suggesting that this could be directly responsible for the cognitive impairment suffered.

In their research, Steiner and colleagues analysed the effects of 2000 compounds, containing both natural substances and FDA-approved drugs, on brain cells in the laboratory. They identified a series of compounds which had the potential to help protect neurons in the brain. Nine of these were related to epicatechin, which is found in cocoa and green tea leaves. Further screening and comparison with resveratrol, the antioxidant found in red wine, specifically identified epicatechin and epigallocatechin gallate (EGCG) as being the most effective at helping protect neurons by inducing production of BDNF.

Although the antioxidant activities of epicatechin and EGCG are well documented, the discovery that they could be responsible for inducing production of BDNF is an exciting advancement in this area. The fact that these compounds readily cross the blood-brain barrier further increases their therapeutic potential, as this is often a major stumbling block in the development of therapies directed at the brain. This provides hope for patients with HIV as there is currently no neuroprotective therapy available for patients with HIV-associated cognitive impairment.

The authors conclude: "Due to its simpler structure and more efficient blood-brain barrier penetration properties, epicatechin might be the best therapeutic candidate for neurodegenerative diseases. These include HIV-associated cognitive disorders where oxidative stress is an important pathophysiological mechanism." Further research in patients with HIV is required to elucidate just how effective these naturally occurring compounds could be.

INFORMATION:

Reference
Nath S, Bachani M, Harshavardhana D, Steiner JP (2012). Catechins protect neurons against mitochondrial toxins and HIV proteins via activation of the BDNF pathway. Journal of NeuroVirology. DOI 10.1007/s13365-012-0122-1

The full-text article is available to journalists on request.

END



ELSE PRESS RELEASES FROM THIS DATE:

Scientists uncover strategy able to dramatically reduce chemotherapy's side effects

2012-08-14
Researchers in Leuven (VIB/KU Leuven) have confirmed their hypothesis that normalizing blood vessels by blocking oxygen sensor PHD2 would make chemotherapy more effective. They also demonstrated for the first time that this strategy would reduce the harmful side effects of chemotherapy on healthy organs. Limited success of chemotherapy The effectiveness of chemotherapy is first and foremost limited by the difficulties of delivering the anticancer drugs to the actual tumor. Tumors are characterized by abnormally shaped blood vessels – they are irregular in shape, have ...

Nearly 1,000 earthquakes recorded in Arizona over 3 years

Nearly 1,000 earthquakes recorded in Arizona over 3 years
2012-08-14
TEMPE, Ariz. – Earthquakes are among the most destructive and common of geologic phenomena. Several million earthquakes are estimated to occur worldwide each year (the vast majority are too small to feel, but their motions can be measured by arrays of seismometers). Historically, most of Arizona has experienced low levels of recorded seismicity, with infrequent moderate and large earthquakes in the state. Comprehensive analyses of seismicity within Arizona have not been previously possible due to a lack of seismic stations in most regions, contributing to the perception ...

Launching a 'social networking war' against cancer

2012-08-14
Experts agree that, more than ever before, modern wars will be fought in the cyber zone, targeting an enemy's communications technology to cause untold damage. Now a Tel Aviv University researcher is suggesting that the same tactics should be employed in the battle against one of the body's deadliest enemies — cancer. In an article published in Trends in Microbiology, Prof. Eshel Ben-Jacob of TAU's School of Physics and Astronomy and Prof. Herbert Levine of Rice University, long-time bacteria researchers, and Prof. Donald Coffey of Johns Hopkins University, a renowned ...

Studies seek better understanding and treatment of depression

Studies seek better understanding and treatment of depression
2012-08-14
AUGUSTA, Ga. – Connecting the dots between two molecules whose levels are decreased in depression and increased by current antidepressants could yield new therapies, researchers say. Serotonin is a neurotransmitter that enables brain cells to communicate and brain-derived neurotropic factor, or BDNF, is a brain-nourishing molecule that also aids connectivity. Popular antidepressants such as Prozac, developed to increase levels of serotonin, have recently been found to also increase BDNF levels, said Dr. Anilkumar Pillai, neuroscientist at the Medical College of Georgia ...

Can specialized HIV community pharmacies improve treatment?

Can specialized HIV community pharmacies improve treatment?
2012-08-14
New Rochelle, NY, August 14, 2012—Community pharmacies with specially trained staff to provide HIV services can help HIV-infected individuals be more compliant with their essential antiviral drug regimens and hence improve patient outcomes. Users of HIV-specialized Walgreen pharmacies across the U.S. had significantly greater adherence to and persistence with their therapeutic drug regimens according to a study published in AIDS Patient Care and STDs, a peer-reviewed journal from Mary Ann Liebert, Inc., publishers. The article is available free on the AIDS Patient Care ...

Closing in on the border between primordial plasma and ordinary matter

2012-08-14
UPTON, NY - Scientists taking advantage of the versatility and new capabilities of the Relativistic Heavy Ion Collider (RHIC), an atom smasher at the U.S. Department of Energy's Brookhaven National Laboratory, have observed first glimpses of a possible boundary separating ordinary nuclear matter, composed of protons and neutrons, from the seething soup of their constituent quarks and gluons that permeated the early universe some 14 billion years ago. Though RHIC physicists have been creating and studying this primordial quark-gluon plasma (QGP) for some time, the latest ...

Impulsive micromanagers help plants to adapt, survive

Impulsive micromanagers help plants to adapt, survive
2012-08-14
EAST LANSING, Mich. — Soil microbes are impulsive. So much so that they help plants face the challenges of a rapidly changing climate. Jen Lau and Jay Lennon, Michigan State University biologists studied how plants and microbes work together to help plants survive the effects of global changes, such as increased atmospheric CO2 concentrations, warmer temperatures and altered precipitation patterns. The results, appearing in the current issue of the Proceedings of the National Academy of Sciences, showed that microbes in the ground not only interact with plants, but they ...

Scientists devise new strategy to destroy multiple myeloma

2012-08-14
Researchers at Virginia Commonwealth University Massey Cancer Center are reporting promising results from laboratory and animal experiments involving a new combination therapy for multiple myeloma, the second most common form of blood cancer. The study published online in the journal Cancer Research details a dramatic increase in multiple myeloma cell death caused by a combination of the drugs obatoclax and flavopiridol. The researchers, led by Steven Grant, M.D., Shirley Carter Olsson and Sture Gordon Olsson Chair in Oncology Research, associate director for translational ...

Success of engineered tissue depends on where it's grown

2012-08-14
CAMBRIDGE, Mass. -- Tissue implants made of cells grown on a sponge-like scaffold have been shown in clinical trials to help heal arteries scarred by atherosclerosis and other vascular diseases. However, it has been unclear why some implants work better than others. MIT researchers led by Elazer Edelman, the Thomas D. and Virginia W. Cabot Professor of Health Sciences and Technology, have now shown that implanted cells' therapeutic properties depend on their shape, which is determined by the type of scaffold on which they are grown. The work could allow scientists to ...

Hearing the telltale sounds of dangerous chemicals

Hearing the telltale sounds of dangerous chemicals
2012-08-14
WASHINGTON, Aug. 14, 2012-- To warn of chemical attacks and help save lives, it's vital to quickly determine if even trace levels of potentially deadly chemicals—such as the nerve gas sarin and other odorless, colorless agents—are present. U.S. Army researchers have developed a new chemical sensor that can simultaneously identify a potentially limitless numbers of agents, in real time. A paper describing the system has been published today in the Optical Society's (OSA) journal, Optics Letters. The new system is based on a phenomenon known as the photoacoustic effect, ...

LAST 30 PRESS RELEASES:

ADC improves outcomes for patients with advanced triple-negative breast cancer who are ineligible for immune checkpoint inhibitors

Novel treatment combination improves progression-free survival in metastatic, estrogen-receptor-positive HER-2-negative breast cancer

ESMO 2025: Trial results show belzutifan shrinks rare neuroendocrine tumors and improves symptoms in patients

ESMO 2025: Dual targeted therapy shows promise in previously treated advanced kidney cancer patients

New generation of Antibody-Drug Conjugates (ADCs) shows unprecedented promise in early-stage disease

Sylvester Cancer Tip Sheet for October 2025

Three science and technology leaders elected to Hertz Foundation Board of Directors

Jump Trading CSO Kevin Bowers elected to Hertz Foundation Board of Directors

Former Inscripta CEO Sri Kosaraju elected to Hertz Foundation Board of Directors

Citadel’s Jordan Chetty elected to Hertz Foundation Board of Directors

McGill research flags Montreal snow dump, inactive landfills as major methane polluters

A lightweight and rapid bidirectional search algorithm

Eighty-five years of big tree history available in one place for the first time

MIT invents human brain model with six major cell types to enable personalized disease research, drug discovery

Health and economic air quality co-benefits of stringent climate policies

How immune cells deliver their deadly cargo

How the brain becomes a better listener: How focus enhances sound processing

Processed fats found in margarines unlikely to affect heart health

Scientists discover how leukemia cells evade treatment

Sandra Shi MD, MPH, named 2025 STAT Wunderkind

Treating liver disease with microscopic nanoparticles

Chemicals might be hitching a ride on nanoplastics to enter your skin

Pregnant patients with preexisting high cholesterol may have elevated CV risk

UC stroke experts discuss current and future use of AI tools in research and treatment

The Southern Ocean’s low-salinity water locked away CO2 for decades, but...

OHSU researchers develop functional eggs from human skin cells

Most users cannot identify AI bias, even in training data

Hurricane outages: Analysis details the where, and who, of increased future power cuts

Craters on surface of melanoma cells found to serve as sites for tumor killing

Research Spotlight: Mapping overlooked challenges in stroke recovery

[Press-News.org] Hope for patients with HIV-associated cognitive impairment
Researchers discover compounds in green tea and chocolate may help reduce neurological complications linked to HIV